JOHN KIRKWOOD to Multicenter Studies as Topic
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Multicenter Studies as Topic.
Connection Strength
0.143
-
Adjuvant therapy with high-dose interferon alpha 2b in patients with high-risk stage IIB/III melanoma. Nat Clin Pract Oncol. 2008 Jan; 5(1):2-3.
Score: 0.065
-
KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol. 2020 Jan; 16(3):4429-4438.
Score: 0.038
-
Adjuvant application of interferons. Semin Oncol. 1996 Dec; 23(6):737-43.
Score: 0.030
-
Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: a report of two clinical trials of the Eastern Cooperative Oncology Group. Invest New Drugs. 2001; 19(1):89-92.
Score: 0.010